Navigation Links
Earnings Forecast Stock Alerts: American International Group, Teva Pharmaceutical, CSX, Exxon Mobil, Lowe's, and Seagate
Date:12/13/2012

VANCOUVER, Dec. 13, 2012 /PRNewswire/ -- EarningForecast.com has issued consensus earnings forecast reports and equity research for the following companies: American International Group (NYSE: AIG), Teva Pharmaceutical (NYSE: TEVA), CSX (NYSE: CSX), Exxon Mobil (NYSE: XOM), Lowe's (NYSE: LOW), and Seagate (NASDAQ: STX).

(Logo: http://photos.prnewswire.com/prnh/20121030/HK02457LOGO )

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

American International Group, Inc. (NYSE: AIG): On December 9, American International Group, Inc. (NYSE: AIG) announced an agreement with an investor group led by Mr. Weng Xianding, the Chairman of New China Trust Co. Ltd. Under the terms of the agreement, American International Group will sell up to a 90% stake in International Lease Finance Corporation to the investor group, in exchange of approximately US$5.28 billion. Investors may want to find out where AIG will go from here. Observing comprehensive American International Group earnings forecast report here.

Read Full Report: http://www.earningforecast.com/PR/121312A/AIG/AmericanInternationalGroup.pdf

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA): Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) shares began the trading session with a price of US$41.07 and throughout the session plunged to a low of US$38.93. When day-trade ended, the stock finally slipped 5.28% to US$39.47. There were 20.87 million stock shares traded, which was 5 times more than average volume. Do you think now is a good time to buy or sell the stock? See TEVA earnings forecast report here.

Read Full Report:

SOURCE EarningForecast.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trovagene, Inc., Announces Third Quarter and Year to Date Earnings, Provides Milestone Update
2. Heska Reports Third Quarter 2012 Earnings
3. Perrigo Reports Record First Quarter Revenue And Adjusted Earnings And Raises Full Year Adjusted EPS Guidance
4. Webcast Alert: Heska Announces Third Quarter 2012 Earnings Conference Call Webcast
5. Psychemedics Corporation Announces 3rd Quarter Earnings
6. Hanger Reports Earnings of $0.50 Per Diluted Share for the Third Quarter 2012
7. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
8. Unilife Corporation Reschedules Release Of Quarterly Results And Earnings Call Due To Severe Weather In Northeastern U.S.
9. Rochester Medical Announces Fourth Quarter 2012 Earnings Conference Call Tuesday, November 13, 2012
10. Compass Diversified Holdings Announces Third Quarter 2012 Earnings and Conference Call Information
11. Trovagene, Inc. Announces Second Quarter and Year to Date Earnings, Provides Milestone Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 3, 2015 The report "Biocides ... acids, Phenolics, and Others) and by Application (Water treatment, ... coatings, and Others) - Global Trends and Forecasts to ... Market with an analysis and forecast for types and ... Browse   88 tables and   63 figures ...
(Date:9/2/2015)... 2015 This report on the multi-parameter ... future prospects of the global market. Multi-parameter patient ... medical practitioners in deciding the treatment regimen as ... Multi-parameter patient monitoring is effective in the management ... is observed to be at a high risk ...
(Date:9/2/2015)... , Sept. 2, 2015 About ... an X-linked disease, which generally affects the male ... and weakness. The disease is caused due to ... the lack of production of dystrophin (a protein ... The lack of dystrophin weakens muscle function, causes ...
Breaking Medicine Technology:Biocides Market Worth 10.6 Billion USD by 2020 2Biocides Market Worth 10.6 Billion USD by 2020 3Biocides Market Worth 10.6 Billion USD by 2020 4Biocides Market Worth 10.6 Billion USD by 2020 5Multi-parameter Patient Monitoring Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Multi-parameter Patient Monitoring Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3
... Schizophrenia is a chronic and disabling brain disorder that ... in substantial medical and societal costs, in particular from ... health-related and social effects on people with the disease, ... from a longer-term clinical study presented at the U.S. ...
... NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical ... therapies, today announced that the Centers for Medicare and ... Health Care Common Procedural Coding System (Level II HCPCS), ... 8% patch. J-codes are used by providers to bill ...
Cached Medicine Technology:Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA® 2Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA® 3Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA® 4Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA® 5Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA® 6NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS) 2NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS) 3NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS) 4
(Date:9/3/2015)... ... September 03, 2015 , ... According to an Oncology ... test that may help patients with oropharyngeal cancer (oral cancer) to be successfully diagnosed ... are often caused by HPV infections, which have a high rate of success in ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters Welcomes Carol ... announce the additional of Carol Wysham, MD, to their esteemed Board of Directors. ... Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda Nicholson and ...
(Date:9/3/2015)... ... September 03, 2015 , ... “We wish to become ... the delicate life balance between work and leisure to the benefit of every ... CEO , A LifeMinder Plus® Emergency Care Document Set duly executed set ensures ...
(Date:9/3/2015)... ... , ... Mum n Me is pleased to announce the launch of its ... gives maximum protection from sun exposure, wind, bugs, and germs. The Mum n Me ... by keeping the cover securely in place. The new car seat cover is made ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... When looking at the types of people ... into one of two categories: those that have a weak appetite or those that have ... still want to gain weight, CB-1 Weight Gainer gives three tips for slowing down metabolism. ...
Breaking Medicine News(10 mins):Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:Mum n Me Announces New Baby Car Seat Cover 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3
... to provide improved accessibility and expanded contentORANGEBURG, S.C., ... company, announces the launch of its updated website. ... URL and can be found at http://www.polymathiclabs.com ... including more information about Polymathic,s services, capabilities, and ...
... Hard to Treat Diseases (HTDS) www.htdsmedical.com the ... Chem (Formerly ReNuYu Biochem) intends to recapitalize to 5 ... the pending China Bio Chem merger. Consideration for Slavica ... amongst all doctors involved in Belgrade Serbia research. Key ...
... TORONTO, Jan. 8 /PRNewswire-FirstCall/ - Med-Emerg International Inc. (OTCBB:MDER) ... is pleased to announce that its shareholders have voted ... (the "Arrangement") with AIM Health Group Inc. ("AIM") at ... today. In excess of 90% of the votes cast ...
... that work, CDC officials stress , , THURSDAY, Jan. 8 (HealthDay ... is resistant to the popular antiviral drug Tamiflu, but government ... , The fact that the flu season so far has ... particular flu virus, has health officials adopting a watchful attitude ...
... May Be Revealed Friday, January 9 WASHINGTON, Jan. ... (SEIU) President Andy Stern convened a conference call ... the forced transfer of 65,000 nursing home and ... (UHW), its third largest affiliate, but delayed the ...
... shape new treatments for secondary pneumoniaMEMPHIS, Tenn., Jan. ... Hospital have demonstrated a more effective treatment for ... antibiotics clindamycin and azithromycin, which kill bacteria by ... a standard first-line treatment with the "beta-lactam" antibiotic ...
Cached Medicine News:Health News:Polymathic Analytical Labs Launches New Website 2Health News:Hard To Treat Diseases (HTDS) Recapitalization 2Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:Common Flu Strain Resistant to Popular Antiviral Drug 2Health News:Common Flu Strain Resistant to Popular Antiviral Drug 3Health News:SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3
Curved shafts with micro Pierse type tips. Flat open serrated handle with dull finish....
Straight shafts with micro Pierse type tips. Flat open serrated handle, dull finish....
Gently curved shafts with pierse tips. Round, knurled handle for finger tip rotation. Excellent for atramatic grasp of corneal flap. Made in titanium....
Straight shafts and serrated handle with polished finish. Teeth: Fine 1 x 2 teeth. Most popular size or model....
Medicine Products: